Bristol Myers Squibb Co (BMY)

Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $119.25B
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Latest financial period: September 30, 2026
Filed with the SEC: October 29, 2026
Estimated earnings date: Not available
Profit #286 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROE/ROA | 79.6% | 80.3% | 76.8% | 43.5% |
Growth #1226 of 1422 companies
Payout #244 of 1422 companies
Safety #979 of 1422 companies
Price #231 of 1422 companies